Associate Prof. Dr. Hasniza Binti Zaman Huri
Department Of Pharmacy
Faculty Of Medicine
hasnizazh@um.edu.my| View CV | |
| ResearcherID Link | |
| Biography | |
|
Hasniza Zaman Huri obtained her PhD (Clinical Pharmacy, Human Genomics & Pharmacogenomics) and Master in Clinical Pharmacy from Universiti Kebangsaan Malaysia and B. Pharm (Honours) from University of Malaya. She is currently an Associate Professor in Clinical Pharmacy and she lectures the clinical pharmacy, pharmaceutical biotechnology and good clinical practice modules. Her research areas cover optimal management of type 2 diabetes mellitus, insulin resistant study (HOMA models), erectile dysfunction, drug related problems and pharmaceutical care issues, biomarkers, pharmacogenomics-pharmacodynamics (single nucleotide polymorphisms using PCR/RFLP and Taqman methods, haplotype analysis, gene interaction study) and gene-disease-drug response modelling. Her research interests also include general endocrinology, urology and obstetrics & gynecology disorders. She has published more than 50 papers in peer reviewed journals related to optimal management, drug-related problems and gene polymorphisms in type 2 diabetes mellitus patients. At present, she is also the Director of Clinical Investigation Centre (CIC), University Malaya Medical Centre - a reputable and multi-winning clinical trial centre in the Asian region. |
|
| Total Articles in Publication List | 47 | |
| Articles With Citation Data | 44 | |
| Sum of the Times Cited | 133 | |
| Average Citations per Article | 3.02 | |
| H-Index | 7 | |
| Co-authors | Collaboration Network | |
| This information is generated from http://researcherid.com | ||
Publication
Finance
| Grant | Progress | Status |
|---|---|---|
| PG056-2014A |
|
on going |
| This information is generated from Research Grant Management System | ||
Altered Circulating Concentrations Of Active Glucagon-Like Peptide (GLP-1) And Dipeptidyl Peptidase 4 (DPP4) In Obese Subjects And Their Association With Insulin Resistance
Drug-related problems in patients with erectile dysfunctions and multiple co-morbidities
Chemokine like receptor- 1 (CMKLR-1) receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2 -oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis : an in vitro study.
Utilisation of Variable Rate Intravenous Insulin Infusion
Hydrolysis, Separation and Purification of Fatty Acids for Bioproducts
Biolubricant Base Oil Synthesis and Its Application: Pharmaceutical and Industrial Applications Based on Enviromental Friendly
Training Manual for Pharmacists for Management of Obesity and Overweight.
Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease
Dyslipidemia and type 2 diabetes mellitus: Implications and role of antiplatelet agents in primary prevention of cardiovascular diseases.